Biosolution will participate in ‘BIO KOREA 5 (Bio Korea 10)’, which will be held at COEX in Seoul for 12 days from Wednesday, May 3th to Friday, 2023th, and demonstrate alternative animal testing methods using human skin models. introduced.
Biosolution, one of the companies with artificial skin technology, is focusing on research, development and commercialization of cell therapy products as expectations for their high potential marketability and utility value increase. In addition to cell therapy, we have developed a human tissue model incorporating cell application technology to provide future growth engines and are focusing on expanding the domestic and overseas markets for human tissue models.
We have human tissue models, including skin, bronchial epithelial mucosa, and oral mucosa, and also provide alternative animal testing services such as hepatotoxicity testing. A human tissue model is an experimental human tissue that is a three-dimensional reconstruction of human tissue with a structure and function similar to that of an actual human tissue using tissue engineering technology from human-derived cell sources. It is used for effectiveness evaluation, etc.
The skin model listed in OECD TG 439 (skin irritation test) has multi-layer differentiated epithelial cell layers and stratum corneum, and can effectively evaluate skin damage and irritation response due to hepatotoxicity.
In addition, the bronchial mucosa model is based on human nasal mucosal epithelial cells and has a structure similar to the human upper respiratory tract. Along with the oral mucosa model, it is considered an economical model that can replace animal testing and clinical trials.
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th anniversary this year, was hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. BIO KOREA, which has been striving to improve the global status and sustainable growth of the Korean health industry since 2006, is solidifying its position as Korea’s representative biohealth international convention with the participation of world-class scholars and business experts every year. BIO KOREA 2023, in collaboration with companies related to the health industry such as domestic and foreign bio, pharmaceuticals, medical devices, cosmetics, and food, as well as interested companies and institutions such as consulting, academia, and related organizations, will be held through various programs such as conferences, business partnering, exhibitions, and investment fairs. It goes on.
→ Go to the BIO KOREA 2023 news special page
